We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
SARS-CoV-2, the virus causing COVID-19, is likely to remain a long-term threat to human health. The typical clinical features - cough, sore throat, fever and diarrhoea - overlap with many other well-established respiratory viruses.
To simplify testing and ensure that patients with compatible symptoms are tested for COVID-19, Mater Pathology has updated the Respiratory Virus Panel to routinely include SARS-CoV-2 (COVID-19). Upper respiratory samples (nasopharyngeal swabs, throat swabs or combined nasal/throat swabs) will have all testing performed at the Main Laboratory in South Brisbane. Other samples (i.e. sputum, broncho-alveolar lavage, endotracheal aspirates etc.) will have the non-COVID-19 virus tests done at Mater, with COVID-19 testing completed by our reference laboratory.
If urgent testing is clinically indicated, please contact the laboratory directly on 07 3163 7500 to discuss the case with a Microbiologist.
07 3163 1524
07 3163 6142
Meet Laura Rodwell, the Nurse Unit Manager of the Cancer Care Centre for Mater Hospital in South Brisbane, she shares her experience of running a cancer care centre ...
52 cyclists and road crew left Cairns on Sunday 2 May embarking on the 15th annual Far North Queensland Smiddy Challenge, in support of cancer research for Mater ...
The second stage of the $100m 10-year Master Plan for Mater Private Hospital Townsville was officially launched today with the start of construction of a new 400 ...
Consumers have voted Mater Baby Products the ‘Purpose-driven Brand Most Likely to Purchase’ and a finalist in the ‘Brand to Watch’ category in the Vote On-Purpose ...